306 related articles for article (PubMed ID: 31578585)
1. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
[TBL] [Abstract][Full Text] [Related]
2. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
Pan ST; Zhou J; Yang F; Zhou SF; Ren T
BMC Cancer; 2020 Jul; 20(1):634. PubMed ID: 32641008
[TBL] [Abstract][Full Text] [Related]
3. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 knockdown increases the therapeutic sensitivity of lung cancer to cisplatin-induced apoptosis by repressing Parkin-related mitophagy and activating the ROCK1 pathway.
Liu Y; Fu Y; Hu X; Chen S; Miao J; Wang Y; Zhou Y; Zhang Y
J Cell Physiol; 2020 Feb; 235(2):1197-1208. PubMed ID: 31270811
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
Pan X; Chen Y; Shen Y; Tantai J
Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma.
Liu Y; Zhang Z; Li Q; Zhang L; Cheng Y; Zhong Z
Oncol Rep; 2020 Aug; 44(2):499-508. PubMed ID: 32627008
[TBL] [Abstract][Full Text] [Related]
7. SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling.
Chen TY; Zhou J; Li PC; Tang CH; Xu K; Li T; Ren T
Med Oncol; 2022 Jan; 39(3):36. PubMed ID: 35059870
[TBL] [Abstract][Full Text] [Related]
8. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
[TBL] [Abstract][Full Text] [Related]
9. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
[TBL] [Abstract][Full Text] [Related]
10. Reduced apurinic/apyrimidinic endonuclease activity enhances the antitumor activity of oxymatrine in lung cancer cells.
Wang Z; Xu W; Lin Z; Li C; Wang Y; Yang L; Liu G
Int J Oncol; 2016 Dec; 49(6):2331-2340. PubMed ID: 27748797
[TBL] [Abstract][Full Text] [Related]
11. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
12. Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin.
Scott TL; Wicker CA; Suganya R; Dhar B; Pittman T; Horbinski C; Izumi T
Mol Carcinog; 2017 Feb; 56(2):325-336. PubMed ID: 27148961
[TBL] [Abstract][Full Text] [Related]
13. Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture.
Wang Z; Liu G; Jiang J
Int J Oncol; 2019 Mar; 54(3):1071-1085. PubMed ID: 30664195
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment.
Liu Y; Zhang Z; Zhang L; Zhong Z
Cell Biochem Funct; 2020 Mar; 38(2):195-203. PubMed ID: 31930546
[TBL] [Abstract][Full Text] [Related]
15. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
[TBL] [Abstract][Full Text] [Related]
17. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
[TBL] [Abstract][Full Text] [Related]
18. PTEN-mediated mitophagy and APE1 overexpression protects against cardiac hypoxia/reoxygenation injury.
Tang W; Lin D; Chen M; Li Z; Zhang W; Hu W; Li F
In Vitro Cell Dev Biol Anim; 2019 Oct; 55(9):741-748. PubMed ID: 31432320
[TBL] [Abstract][Full Text] [Related]
19. APE1 modulates cellular responses to organophosphate pesticide-induced oxidative damage in non-small cell lung carcinoma A549 cells.
Thakur S; Dhiman M; Mantha AK
Mol Cell Biochem; 2018 Apr; 441(1-2):201-216. PubMed ID: 28887667
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]